Topics
- Medical Aspects and Regulatory issues
- Molecular Genetic Etiology
- Rare Case Studies and Reports
- Genetics and Epigenetics
- Global Rare Diseases and Orphan Drug Market
- Orphan Drugs Clinical Research
- Prevalence, Epidemiology and Forecasting
- Health Policies and Services Organization
- Genomics and Proteomics of Rare Disease
- Pharmacology and Toxicology
- Post-Marketing Safety and Treatment Outcomes
- Gene and Stem Cell Therapy
- Drug Discovery and Developments
- Clinical Research and Developments
- Molecular Genetics
- Translational Science
- Access and Pricing
- Medical Affairs and Regulatory Affairs
- Biomedical Research and Rare Diseases
- Rare Genetic Diseases/Disorders
- Transforming care for rare diseases
- Orphan Drug Therapeutics
- Diagnosis and Challenges
- Revolutionary Changes
- Rare Diseases and Ultra Rare Diseases
- Advancing Research for rare diseases
Who should Attend
Scholars, academics, industry leaders, and enthusiasts
